SCCR Indonesia is a leading pharmaceutical industry in the field of research and healthcare services, particularly in the development of stem cell therapies and cancer research. SCCR Indonesia has obtained permits from the Ministry of Health and the Ministry of Investment, signed by the Head of the Investment Coordinating Board with the number 03032200130070009, as well as cGMP certification from the National Agency of Drug and Food Control (BPOM) with the number PW-S.01.04.1.3.333.03.25-0034. Currently equipped with a stem cell laboratory facility supported by international researchers, SCCR Indonesia is committed to delivering globally standardized medical innovations. As a pharmaceutical industry certified by BPOM and cGMP standards, SCCR Indonesia focuses on providing research-based healthcare solutions to support patients’ quality of life and the advancement of biomedical science.
In the division of foundamnetal research is divided into :
- Isolation and culture of stem cell and cancer
stem cell - Cell sorting and engineering stem cell and
cancer stem cell - Secretome and paracrine signaling stem cell
and cancer stem cell
in the division of applied research are
divided into :
- Autoimmune disease
- Degenerative disease
Wound healing dissease